Long non-coding RNA cartilage injury-related (lncRNA-CIR) (lncRNA-CIR)

VIM2P (vimentin 2, pseudogene) refers to a genomic locus annotated as a pseudogene related to the vimentin (VIM) gene, but it does not code for a functional protein. Some of its aliases (such as lncRNA-CIR) indicate it is classified as a long non-coding RNA, which are RNA molecules longer than 200 nucleotides and not translated into proteins. lncRNAs like these are involved in chromatin-remodeling, transcriptional regulation, and epigenetic modification, often with high cell-type specificity and low sequence conservation[2][6][4]. The alternative names and presumed functions (cartilage injury-related) are based on their initial discovery or experimental findings but are not universally recognized or validated. Notes on correctness: - There is evidence of confusion: "vimentin 2, pseudogene" (VIM2P) is *not* a classical therapeutic target such as a receptor, enzyme, or transporter. - The aliases and the variety of names (including lncRNA-CIR, VIM2P, RP11-162L10.1, etc.) may refer to overlapping, synonymous, or slightly different lncRNAs or pseudogenes in various genome annotation resources. - While the canonical vimentin gene (VIM) is very well-studied, VIM2P as a pseudogene or as lncRNA-CIR has much less established biology, limited functional data, and is not a defined clinical or drug target[3][1]. - Most evidence points to its classification as a lncRNA/pseudogene, not a protein-coding gene or a molecule with a well-defined disease mechanism or pharmacological targeting profile. If structured curation is required for databases, consider *excluding* VIM2P as an actionable therapeutic target and flagging for expert genetics review.

Other names

VIM2Pvimentin 2, pseudogeneRP11-162L10.1VIM2CIRlong non-coding RNA cartilage injury-relatedVIMP1vimentin pseudogene 1 (functional)

not applicable (as drugs targeting it aren't described)